Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 16 ... for virtually all cases of cervical cancer. Three of the project's four experimental HPV vaccines will be tested at UAB, said Warner Huh, M.D., an associate scientist in the UAB ...
2009 NOV 2 ... NEARLY ALL WOMEN ARE AT RISK FOR BECOMING INFECTED WITH THE HUMANPAPILLOMA VIRUS ? OR HPV ? WHICH CAN CAUSE CERVICAL CANCER, THE SECOND LEADING CAUSE OF CANCER DEATH IN WOMEN IN ... IN GIRLS AND YOUNG WOMEN BETWEEN THE AGES OF 10 AND 25. Keywords: Cancer Vaccines, Cervical Cancer, Cervical Carcinoma, GlaxoSmithKline, Immunization, Oncology, ...
2009 NOV 2 ... women to protect against cervical pre-cancers and cervical cancer caused by oncogenic HPV 16 and 18. The ACIP specifically recommended CERVARIX for routine administration among ... Additionally, the ACIP unanimously recommended to provide funding for CERVARIX from the Vaccines for Children (VFC) program. The federally funded program provides vaccines at no cost to ...
2009 NOV 16 ... research from the United States, "Anal condyloma acuminatum is a human papillomavirus (HPV) that affects the mucosa and skin of the anorectum and genitalia. Anal condyloma ... anal condyloma acuminatum; however, recently Gardasil and Cervarix (in Australia only) vaccines have become available and are showing promising results." Mccutcheon and ...
2009 NOV 23 ... newly published data in Clinical Microbiology and Infection. "Human papilloma viruses (HPV) are strong human carcinogens, in fact today they are considered as the second most ... Recently, the prophylactic bivalent HPV 16/18 and the quadrivalent HPV 6/11/16/18/ vaccines have been approved," wrote E. Galani and colleagues, . The researchers ...
2009 NOV 29 ... cervical cancer. The mice were genetically engineered to carry human papillomavirus (HPV) 16, known to be strongly associated with cervical cancer.HPV is also the ... the most common sexually transmitted infection in women in the United States. While new vaccines can prevent some of the many kinds of HPV infections, they do not eliminate ...
2009 NOV 23 ... across Canada would inform public health decisions regarding implementation of anti-HPV vaccines. A total of 8,700 liquid-based specimens from 8,660 women aged 13-86 from throughout ...
2009 NOV 16 ... Rochester, MN 55905, USA. Keywords: United States, Pasadena, Biotechnology, HPV Vaccines, Human Papillomavirus Vaccines, Immunization, Managed Care, Vaccination, Vaccine ...
2009 NOV 2 ... and have the potential to prevent cervical cancer in 70-80% of HPV- naive women. HPV vaccines have been first licensed for use in girls and women aged 9-26 years. However, women over ...
2009 NOV 2 ... "The amino (N) terminus of the human papillomavirus (HPV) minor capsid protein L2 can induce low-titer, cross-neutralizing antibodies. The aim of ... (Chimeric L1-L2 Virus-Like Particles as Potential Broad-Spectrum Human Papillomavirus Vaccines. Journal of Virology, 2009;83(19):10085-10095). For additional information, ...
2009 NOV 16 ... study' have been presented. "No recent data exist on human papillomavirus (HPV) infection in Beijing, People's Republic of China. We interviewed and examined a ... NY 10010-1707, USA. Keywords: People's Republic of China, Beijing, Cancer Vaccines, DNA, HPV, Human Papillomavirus, Immunization, Oncology, Women's Health. ...
2009 NOV 3 ... of genital warts cases in Singapore, which are caused by the human papilloma virus (HPV). An HPV vaccine is already available in Singapore, as a protection against both genital ... and Swiss Lonza are investing in local manufacturing facilities for the production of vaccines and cell-based therapeutics, respectively. Similarly, the June 2009 inauguration of the ...
2009 NOV 2 ... The researchers concluded: "By vaccinating with the quadrivalent HPV vaccine, there are significant savings to be made." Dee and colleagues ... Genital Warts, Genitourinary Medicine, HPV, Human Papillomavirus, Immunization, Urology, Vaccines. This article was prepared by OBGYN & Reproduction Week editors from staff ...
2009 NOV 9 ... Cancer Vaccines, Central Nervous System Disease, Dermatology, Genital Warts, HPV Vaccines, Human Papillomavirus Vaccines, Immunization, Infectious Disease, Meningococcal ...
